Compass Therapeutics, Inc. (CMPX)

Compass Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	46.21	43.48	24.23	34.95	144.51	47.08
Short-Term Investments	173.68	83.24	128.23	151.66	-	-
Cash & Short-Term Investments	219.9	126.72	152.46	186.61	144.51	47.08
Cash Growth	62.40%	-16.88%	-18.30%	29.13%	206.98%	86.05%
Prepaid Expenses	1.23	6.03	1.42	8.18	2.59	3.13
Total Current Assets	221.12	132.75	153.88	194.79	147.11	50.2
Property, Plant & Equipment	9.57	7.08	2.67	4.53	6.33	1.13
Other Long-Term Assets	0.57	0.57	0.32	0.32	0.32	0.58
Total Assets	231.26	140.4	156.88	199.65	153.76	51.91
Accounts Payable	3.1	2.25	4.09	3.38	0.87	1.06
Accrued Expenses	8.68	6.29	2.51	11.69	8.78	1.57
Current Portion of Long-Term Debt	-	-	-	-	-	7.47
Current Portion of Leases	0.63	0.34	1.2	1.1	0.99	-
Total Current Liabilities	12.41	8.87	7.8	16.17	10.63	10.1
Long-Term Debt	-	-	-	-	-	1.87
Long-Term Leases	9.23	6.3	0.54	1.84	3.05	-
Total Liabilities	21.65	15.17	8.34	18.01	13.68	11.97
Common Stock	0.05	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	624.74	489.69	463.8	454.74	373.66	191.35
Retained Earnings	-415.46	-364.68	-315.31	-272.81	-233.59	-151.41
Comprehensive Income & Other	0.27	0.21	0.04	-0.3	-	-
Total Common Equity	209.61	125.23	148.54	181.64	140.08	39.95
Shareholders' Equity	209.61	125.23	148.54	181.64	140.08	39.95
Total Liabilities & Equity	231.26	140.4	156.88	199.65	153.76	51.91
Total Debt	9.87	6.63	1.73	2.94	4.04	9.33
Net Cash (Debt)	210.03	120.09	150.73	183.67	140.48	37.74
Net Cash Growth	63.41%	-20.33%	-17.94%	30.75%	272.20%	279.70%
Net Cash Per Share	1.44	0.87	1.19	1.75	2.23	1.23
Filing Date Shares Outstanding	177.86	138.28	137.59	126.31	100.83	51.22
Total Common Shares Outstanding	177.57	137.82	127.67	126.3	100.83	51.22
Working Capital	208.71	123.88	146.08	178.62	136.47	40.1
Book Value Per Share	1.18	0.91	1.16	1.44	1.39	0.78
Tangible Book Value	209.61	125.23	148.54	181.64	140.08	39.95
Tangible Book Value Per Share	1.18	0.91	1.16	1.44	1.39	0.78
Machinery	4.76	4.74	5.19	5.16	5.37	5.99
Leasehold Improvements	1.61	1.61	1.61	1.61	1.53	0.9

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q